drugset / Trial / NCT00784732

A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

NCT00784732

Phase 2 Completed 44 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the effectiveness of QAV680 against placebo in treating the symptoms of seasonal allergic rhinitis in an Environmental Exposure Chamber.

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mometasone furoate Other / unclassified
Subject QAV680 Small molecule